Search - tctmd.com

Displaying 401 - 420 of 1353

Sort: Relevancy | Date

Presentation TCT 2022

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

Presenter: Charles Davidson

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Presenter: Charles J. Davidson

September 19, 2022

Presentation TCT 2022

Clinical Trial Updates: A Selective Review of What All Operators Should Know

Presenter: John Carroll

September 18, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

Presenter: Bahira Shahim

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

Presentation TCT 2022

Clinical Implications of PROTECTED TAVR: A Neurologist’s Perspective

Presenter: Steven Messe

September 17, 2022

Presentation TCT 2022

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Presenter: Jonas Lanz

September 17, 2022

Advertisement

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Clinical Trial Updates: A Selective Review of What All Operators Should Know

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

Ongoing Clinical Trials and the Future of LAAC

Recent Clinical Trials & Registries: Update 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Clinical Implications of PROTECTED TAVR: A Neurologist’s Perspective

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content